Dr. Reekmans SRL
Dr. Reekmans reported total assets of 464,779 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jun 2026).
The score of Dr. Reekmans shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -30 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Reekmans's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 85,878 € | ||||
| Equity | 349,418 € | ||||
| Cash | 309,559 € | ||||
| EBITDA | 145,579 € | ||||
| Total assets | 464,779 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Dr. Reekmans's financial analysis
- Solvency75.2%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Reekmans
Dr. Reekmans's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.347.974
- VAT number
- BE0877347974
- Peppol
- Registered · 0208:0877347974 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Nov 2005
- Registered office
- 1790 Affligem
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Reekmans (SRL) has been based in Affligem since 2005, active in: medical specialists activities. For 2025, it reports a net profit of 85,878 € and equity of 349,418 €; its revenue is not published. Its solvency stands at 75.2%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Reekmans
Companies in the same business, of comparable size and area, outside its group.
- Stevan Grondwerken Manufacture of basic pharmaceutical products Izegem · balance sheet 464,887 €
- Patria Namur · balance sheet 465,050 €
- Mannequins Bonami Other manufacturing n.e.c. Aalter · balance sheet 464,439 €
- Matlys Lier · balance sheet 465,274 €
- Dierickx Huisartsen Heuvelland · balance sheet 464,834 €
- GS Immo Waimes · balance sheet 464,719 €
- Rasson-Witdouck Tournai · balance sheet 464,913 €
Frequently asked questions about Dr. Reekmans
What is the revenue of Dr. Reekmans?
Dr. Reekmans files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Reekmans?
In Belgium, the VAT number is the company number prefixed with BE: BE0877347974 for Dr. Reekmans, if the company is VAT-registered. Its company number (CBE) is 0877.347.974.
Where is the registered office of Dr. Reekmans?
According to the CBE register, the registered office of Dr. Reekmans is in 1790 Affligem.
What is the equity of Dr. Reekmans?
At the close of the 2025 financial year, the equity of Dr. Reekmans amounts to 349,418 €, a solvency of 75.2% of total assets.
Who manages Dr. Reekmans?
The register lists 1 active mandates at Dr. Reekmans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Reekmans
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →